Published in
Springer, Targeted Oncology, 4(16), p. 485-492, 2021
DOI: 10.1007/s11523-021-00820-7
Links
Tools
Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study
Journal article published in 2021 by
Almudena Callejo,
Sara Faouzi,
Olivier Bouché,
François Bertucci 
,
Thomas Chevalier,
Nicolas Isambert,
Florence Duffaud,
Olivier Collard,
Nicolas Penel,
Philippe Terrier,
Olivier Mir ,
Jean Yves Blay,
Axel Le Cesne
,
Thomas Chevalier,
Nicolas Isambert,
Florence Duffaud,
Olivier Collard,
Nicolas Penel,
Philippe Terrier,
Olivier Mir ,
Jean Yves Blay,
Axel Le Cesne
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 